参考文献/References:
[1] TAYLOR S E, WIELD A, FANG Yusi, et al. Endocrinebiomarkers in low-grade serous ovarian cancers(LGSC)and serous ovarian tumors of low malignantpotential(LMP)[J]. Journal of Clinical Oncology, 2020,38(suppl 15): e18045.
[2] SHI Yuchuan, HE Runhua, YANG Yu, et al. CircularRNAs: novel biomarkers for cervical, ovarian andendometrial cancer (review)[J]. Oncology Reports,2020, 44(5): 1787-1798.
[3] 黄梨, 龙佑梅, 付义霞, 等. 紫檀芪对卵巢癌SKOV3细胞凋亡和糖酵解的影响及机制研究[J]. 实用肿瘤学杂志,2019,33(6):502-507.HUANG Li, LONG Youmei, FU Yixia, et al. Effect ofpterostilbene on apoptosis and glycolysis of ovariancancer SKOV3 cells and its mechanism [J]. PracticalOncology Journal, 2019, 33(6): 502-507.
[4] CHIANG Y C, LIN H W, CHANG C F, et al.Overexpression of CHI3L1 is associated withchemoresistance and poor outcome of epithelial ovariancarcinoma.[J]. Oncotarget, 2015, 6(37) : 39740-39755.
[5] SU C W, CHEN M K, HUNG W C, et al. Functionalvariant of CHI3L1 gene is associated with neck metastasisin oral cancer[J]. Clinical Oral Investigations,2019, 23(6) : 2685-2694.
[6] WANG Y, ZHONG M, WANG W, et al. CHI3L1regulates APAP-induced liver injury by promotingmacrophage infiltration[J]. European review formedical and pharmacological sciences, 2019, 23(11) :4996-5003.
[7] LUO Dingyuan, CHEN Haibo, LUO Penghui ,et al.CHI3L1 overexpression is associated with metastasisand is an indicator of poor prognosis in papillarythyroid carcinoma[J]. Cancer Biomarkers: Section A ofDisease Markers, 2017, 18(3) : 273-284.
[8] ANSARI K I, BHAN A, LIU Xueli, et al. AstrocyticIGFBP2 and CHI3L1 in cerebrospinal fluid drivecortical metastasis of HER2+breast cancer[J]. Clinical& Experimental Metastasis, 2020, 37(3): 401-412.
[9] LIU Kaitai, JIN Ming, YE Shuang, et al. CHI3L1promotes proliferation and improves sensitivity tocetuximab in colon cancer cells by down‐regulatingp53[J]. Journal of Clinical Laboratory Analysis, 2020,34(1) : e23026.
[10] KAINULAINEN H. CHI3L1--a novel myokine[J].Acta Physiologica (Oxford, England), 2016, 216(3):260-261.
[11] 张巧娣, 谢而付, 凌芸, 等. 壳多糖酶3 样蛋白1 与甲胎蛋白在肝细胞癌诊断中的比较[J]. 现代检验医学杂志,2017,32(1):45-47, 52.ZHANG Qiaodi, XIE Erfu, LING Yun, et al.Comparative diagnostic value of chitinase 3-like 1protein and AFP in the diagnosis of hepatocellularcarcinoma [J]. Journal of Modern Laboratory Medicine,2017, 32(1):45-47,52.
[12] 石玉如，岳莉，赵长城，等．血清壳多糖酶3 样蛋白1 检测在不同肝脏疾病中的应用价值[J]. 现代检验医学杂志,2017,32(6):39-42.SHI Yuru, YUE Li, ZHAO Changcheng, et al. Clinicalapplication value of chitinase-3-like protein 1 inpatients with different liver diseases [J]. Journal ofModern Laboratory Medicine, 2017, 32(6):39-42.
[13] LIBREROS S, GARCIA-AREAS R, SHIBATA Y, et al.Induction of proinflammatory mediators by CHI3L1 isreduced by chitin treatment: decreased tumor metastasisin a breast cancer model[J]. International Journal ofCancer, 2012, 131(2): 377-386.
[14] KU B M, LEE Y K, RYU J, et al. CHI3L1 (YKL-40) isexpressed in human gliomas and regulates the invasion,growth and survival of glioma cells[J]. InternationalJournal of Cancer, 2011, 128(6): 1316-1326.
[15] KAWADA M, SENO H, KANDA K, et al. Chitinase3-like 1 promotes macrophage recruitment andangiogenesis in colorectal cancer[J]. Oncogene, 2012,31(26): 3111-3123.
[16] KIM E G, KIM M N, HONG JY, et al. Chitinase 3-Like1 contributes to food allergy via M2 macrophagepolarization[J]. Allergy Asthma & ImmunologyResearch, 2020, 12(6): 1012-1028.
[17] WURM J, BEHRINGER S P, RAVI V M, et al.Astrogliosis releases Pro-Oncogenic chitinase 3-Like 1causing MAPK signaling in glioblastoma[J]. Cancers,2019, 11(10): 1437.
相似文献/References:
[1]顾益凤,朱自力,张金业,等.利用ROC曲线选择血清HE-4对卵巢癌的最佳诊断界点[J].现代检验医学杂志,2015,30(04):141.[doi:10.3969/j.issn.1671-7414.2015.04.043]
GU Yi-feng,ZHU Zi-li,ZHANG Jin-ye,et al.Selecting the Best Cut-off Point
of Serum HE-4 in Ovarian Cancer by ROC Curve[J].Journal of Modern Laboratory Medicine,2015,30(04):141.[doi:10.3969/j.issn.1671-7414.2015.04.043]
[2]郑福利,张颖,王建.血清S100A6检测对卵巢上皮性癌的诊断价值[J].现代检验医学杂志,2015,30(05):22.[doi:10.3969/j.issn.1671-7414.2015.05.007]
ZHENG Fu-li,ZHANG Ying,WANG Jian.Study on Diagnostic Value of Detecting Serum S100A6
in the Epithelial Ovarian Carcinoma[J].Journal of Modern Laboratory Medicine,2015,30(04):22.[doi:10.3969/j.issn.1671-7414.2015.05.007]
[3]詹颉,常宁宁,李小侠,等.CEA，AFP，CA125，CA199和CA72-4联合检测在鉴别卵巢良恶性疾病中的应用价值[J].现代检验医学杂志,2015,30(05):50.[doi:10.3969/j.issn.1671-7414.2015.05.015]
ZHAN Jie,CHANG Ning-ning,LI Xiao-xia,et al.Clinical Value of Combined Detection of CEA，AFP，CA125，CA199 and
CA72-4 in the Identification of Ovarian Benign and Malignant Disease[J].Journal of Modern Laboratory Medicine,2015,30(04):50.[doi:10.3969/j.issn.1671-7414.2015.05.015]
[4]邢瑞青,吴永昌,陈慧昱,等.血清CA125,HE4及ROMA指数对卵巢癌诊断价值的临床研究[J].现代检验医学杂志,2016,31(06):37.[doi:10.3969/j.issn.1671-7414.2016.06.010]
XING Rui-qing,WU Yong-chang,CHEN Hui-yu,et al.Diagnostic Value of Serum CA125,HE4 and ROMA Index in Patients with Ovarian Cancer[J].Journal of Modern Laboratory Medicine,2016,31(04):37.[doi:10.3969/j.issn.1671-7414.2016.06.010]
[5]张 悦a,段海霞,暴 蕾a,等.microRNA-125b在葛根素诱导人卵巢癌细胞SKOV3凋亡中的作用研究[J].现代检验医学杂志,2017,32(05):13.[doi:10.3969/j.issn.1671-7414.2017.05.004]
ZHANG Yuea,DUAN Hai-xia,BAO Leia,et al.Role of MicroRNA-125b in Human Ovarian Cancer Cell
SKOV3 Induced Apoptosis by Puerarin[J].Journal of Modern Laboratory Medicine,2017,32(04):13.[doi:10.3969/j.issn.1671-7414.2017.05.004]
[6]徐金良a,杜丹丹,翟志敏,等.卵巢良恶性肿瘤患者血液NLR,LMR,RDW,PLR四项参数的变化及其临床意义[J].现代检验医学杂志,2018,33(02):16.[doi:10.3969/j.issn.1671-7414.2018.02.001]
XU Jin-lianga,DU Dan-dan,ZHAI Zhi-min,et al.Changes and Clinical Significance of Four Parameters of NLR,LMR,
RDW and PLR in Patients with Benign and Malignant Ovarian Tumors[J].Journal of Modern Laboratory Medicine,2018,33(04):16.[doi:10.3969/j.issn.1671-7414.2018.02.001]
[7]马同敏,赵志强.血清CA125,STIP1和IGF-Ⅰ联合检测对卵巢癌的早期诊断价值研究[J].现代检验医学杂志,2018,33(06):50.[doi:10.3969/j.issn.1671-7414.2018.06.013]
MA Tong-min,ZHAO Zhi-qiang.Clinical Value of Combined Detection of Serum CA125,STIP1 and IGF-I Levels in Early Diagnosis of Ovarian Cancer[J].Journal of Modern Laboratory Medicine,2018,33(04):50.[doi:10.3969/j.issn.1671-7414.2018.06.013]
[8]张善弟,荆成宝,禹 梅.血清CEA,CA125和HE4联合检测对卵巢癌的诊断价值[J].现代检验医学杂志,2018,33(06):122.[doi:10.3969/j.issn.1671-7414.2018.06.032]
ZHANG Shan-di,JING Cheng-bao,YU Mei.Clinical Value of Combined Detection of Serum CEA,CA125 and HE4 in the Diagnosis of Ovarian Cancer[J].Journal of Modern Laboratory Medicine,2018,33(04):122.[doi:10.3969/j.issn.1671-7414.2018.06.032]
[9]刘 青,邓慧敏,周林涛,等.卵巢癌患者组织中miR-135b的表达及临床意义[J].现代检验医学杂志,2019,34(02):32.[doi:10.3969/j.issn.1671-7414.2019.02.009]
LIU Qing,DENG Hui-min,ZHOU Lin-tao,et al.Expression and Clinical Significance of miR-135bin Tissues of Patients with Ovarian Cancer[J].Journal of Modern Laboratory Medicine,2019,34(04):32.[doi:10.3969/j.issn.1671-7414.2019.02.009]
[10]侯 娟,蒋树立,滕长财.基于TCGA 数据库卵巢癌患者的miR-301b 表达量与生存状况生物信息学分析[J].现代检验医学杂志,2020,35(04):37.[doi:10.3969/j.issn.1671-7414.2020.04.009]
HOU Juan,JIANG Shu-li,TENG Chang-cai.Bioinformatics Analysis of Mir-301b Expression and Survival Status of Patients with Ovarian Cancer Based on TCGA Database[J].Journal of Modern Laboratory Medicine,2020,35(04):37.[doi:10.3969/j.issn.1671-7414.2020.04.009]